A PROSPECTIVE-STUDY OF PERITONEAL TRANSPORT IN CAPD PATIENTS

被引:103
作者
STRUIJK, DG
KREDIET, RT
KOOMEN, GCM
BOESCHOTEN, EW
HOEK, FJ
ARISZ, L
机构
[1] UNIV AMSTERDAM, ACAD MED CTR, DEPT CLIN CHEM, 1105 AZ AMSTERDAM, NETHERLANDS
[2] FDN HOME DIALYSIS, UTRECHT, NETHERLANDS
关键词
D O I
10.1038/ki.1994.226
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A prospective two year follow-up study of the functional characteristics of the peritoneal membrane was conducted in 61 CAPD patients. Peritoneal transport of solutes, calculated by mass transfer area coefficients for urea and creatinine, peritoneal clearances for proteins, percentage of absorption of glucose, as well as net ultrafiltration were measured every four months. After five months on CAPD a decrease was found for the transport of most solutes (P < 0.05, mean values, ml/min/1.73 m(2)): urea 18.1 to 16.2, creatinine 9.5 to 8.4, IgG 0.049 to 0.040 and alpha(2)-macroglobulin 0.020 to 0.015, as well as for the absorption of glucose (57.9 to 53.2%, P < 0.05). Net ultrafiltration increased simultaneously from 44.6 to 100.5 ml/4 hr/1.73 m(2), P < 0.05. From five months to two years on CAPD a significant increase in the transport of all solutes except alpha(2)-macrogrobulin was found, as well as a decrease in net ultrafiltration. Peritoneal transport at the end of the study was not significantly different from the starting values. Our findings indicate an initial effect of CAPD itself on peritoneal transport, probably due to the recent start of the treatment. Baseline values were reached after five months on CAPD. Thereafter a gradual increase in peritoneal solute transport occurred during two years of treatment. This can be explained by an increase in the effective peritoneal surface area.
引用
收藏
页码:1739 / 1744
页数:6
相关论文
共 49 条
[1]   IMMUNO-EFFECTOR CHARACTERISTICS OF PERITONEAL-CELLS DURING CAPD TREATMENT - A LONGITUDINAL-STUDY [J].
BETJES, MGH ;
TUK, CW ;
STRUIJK, DG ;
KREDIET, RT ;
ARISZ, L ;
HOEFSMIT, ECM ;
BEELEN, RHJ .
KIDNEY INTERNATIONAL, 1993, 43 (03) :641-648
[2]  
BLAKE PG, 1989, ADV PERIT D, V5, P3
[3]   CHEMICAL MEASUREMENTS OF INULIN CONCENTRATIONS IN PERITONEAL-DIALYSIS SOLUTION [J].
BROWN, P ;
NOLPH, KD .
CLINICA CHIMICA ACTA, 1977, 76 (01) :103-112
[4]  
BURTON PR, 1987, LANCET, V1, P1115
[5]   LONG-TERM PERITONEAL CLEARANCES IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].
CHAN, PCK ;
CHAN, CY ;
WU, PG ;
CHENG, IKP ;
CHAN, MK .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1990, 13 (10) :707-708
[6]  
FALLER B, 1984, PERITON DIALYSIS B, V4, P10
[7]   PERITONEAL CLEARANCE OF CREATININE AND INULIN DURING DIALYSIS IN DOGS - EFFECT OF SPLANCHNIC VASODILATORS [J].
FELT, J ;
RICHARD, C ;
MCCAFFREY, C ;
LEVY, M .
KIDNEY INTERNATIONAL, 1979, 16 (04) :459-469
[8]  
FIJEN JW, 1988, NETH J MED, V33, P270
[9]  
Gokal R, 1987, Nephrol Dial Transplant, V2, P172
[10]   PERITONEAL-DIALYSIS SOLUTIONS AND FELINE SPLANCHNIC BLOOD-FLOW [J].
GRANGER, DN ;
ULRICH, M ;
PERRY, MA ;
KVIETYS, PR .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1984, 11 (05) :473-481